Cipher Pharmaceuticals Profit Margin

As of the most recent data (March 2026), CPHRF shows a profit margin of 60.82%. That compares with 23.4% in the prior-year period — up 159.9% year over year. That is above the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CPHRF's profit margin is now 60.82% (was 23.4%) — a 159.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cipher Pharmaceuticals is outperforming or lagging.

The Healthcare sector average profit margin is about 15.58%. Cipher Pharmaceuticals is at 60.82%, which is higher that average. That is roughly 290.3% above the sector mean. Use the comparison chart on this page to see how CPHRF stacks up against individual peers as well.

That compares with 23.4% in the prior-year period — up 159.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Cipher Pharmaceuticals with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Cipher Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 60.82%) with ownership activity and broader fundamentals.